Glucosamine and Chondroitin Effects

Completed · Not applicable · Has a placebo group

Conditions studied: Inflammation

In brief

A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected by a reduction in serum C-reactive protein.

Key facts

Study ID

NCT01682694

Run by

Fred Hutchinson Cancer Center

People needed

20

Starts

2012-09-01

Expected to finish

2013-08-01

Last updated by the study team

2014-05-28

Who can join

Age: 20 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy
• Overweight (body mass index kg/m2 (BMI) between 25 and 32.5)
• Non-smoking men and women
• Aged 20-55y

You may not qualify if…

• Chronic medical illness, history of gastrointestinal, hepatic, or renal disorders, or inflammatory conditions (including autoimmune and inflammatory diseases)
• Pregnancy or lactation
• Currently on a weight-loss diet
• BMI (body mass index) < 25 or > 30
• Alcohol intake of greater than 2 drinks/day
• Current use of prescription or over-the-counter medications, (Excluding oral contraceptives and hormone-secreting IUDs), including use of aspirin or NSAIDs more than 2 days per week
• Abnormal renal, liver or metabolic test
• Inability to swallow pills
• Known allergy to shellfish
• Not willing to take pills made from shellfish or animal sources
• Intention to relocate out of study area within next 4 months

Where it is running

• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.